Cargando…
Gemcitabine Induces Microvesicle Particle Release in a Platelet-Activating Factor-Receptor-Dependent Manner via Modulation of the MAPK Pathway in Pancreatic Cancer Cells
Studies, including ours, have shown that pro-oxidative stressors, such as chemotherapeutic agents, generate oxidized lipids with agonistic platelet-activating factor (PAF) activity. Importantly, recent reports have implicated that these PAF-agonists are transported extracellularly via microvesicle p...
Autores principales: | Thyagarajan, Anita, Kadam, Sayali M., Liu, Langni, Kelly, Lisa E., Rapp, Christine M., Chen, Yanfang, Sahu, Ravi P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337552/ https://www.ncbi.nlm.nih.gov/pubmed/30577630 http://dx.doi.org/10.3390/ijms20010032 |
Ejemplares similares
-
Topical application of gemcitabine generates microvesicle particles in human and murine skin
por: Thyagarajan, Anita, et al.
Publicado: (2022) -
Platelet-Activating Factor-Receptor Signaling Mediates Targeted Therapies-Induced Microvesicle Particles Release in Lung Cancer Cells
por: Chauhan, Shreepa J., et al.
Publicado: (2020) -
Exposure to diesel exhaust particulates and desert sand dust generates microvesicle particles and platelet‐activating factor agonists
por: Thyagarajan, Anita, et al.
Publicado: (2023) -
Systemic Platelet-Activating Factor-Receptor Agonism Enhances Non-Melanoma Skin Cancer Growth
por: Romer, Eric, et al.
Publicado: (2018) -
Radiation therapy produces microvesicle particle release in HaCaT keratinocytes
por: Torralba, Ericson John V., et al.
Publicado: (2023)